Skip to main content
Advertisement
Advertisement

SNOA

SNOA logo

Sonoma Pharmaceuticals, Inc. Common Stock

1.25
USD
Sponsored
0.00
-0.40%
Sep 24, 15:57 UTC -4
Closed
exchange

Pre-Market

1.29

+0.04
+3.53%

SNOA Earnings Reports

Positive Surprise Ratio

SNOA beat 11 of 21 last estimates.

52%

Next Report

Date of Next Report
Nov 02, 2026
Estimate for Q2 27 (Revenue/ EPS)
$5.39M
/
-$0.10
Implied change from Q1 27 (Revenue/ EPS)
--
/
--
Implied change from Q2 26 (Revenue/ EPS)
-3.77%
/
-68.75%

Sonoma Pharmaceuticals, Inc. Common Stock earnings per share and revenue

On Aug 05, 2026, SNOA reported earnings of -- USD per share (EPS) for Q1 27, -- the estimate of -0.30 USD, resulting in a --% surprise. Revenue reached --, compared to an expected 5.09 million, with a --% difference.
Looking ahead to Q2 27, 3 analysts forecast an EPS of -0.10 USD, with revenue projected to reach 5.39 million USD, implying an -- of --% EPS, and -- of --% in Revenue from the last quarter.

Industry Peers’ Earnings

Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.

logo
PharmaCyte Biotech, Inc. Common Stock
Report Date
Sep 14, 2026 For Q1 27
Estimate
-
Actual
-$0.54
Surprise
-
FAQ
For Q1 2027, Sonoma Pharmaceuticals, Inc. Common Stock reported EPS of --, missing estimates by --, and revenue of --, -- -- expectations.
The stock price moved -- --, changed from -- before the earnings release to -- the day after.
The next earning report is scheduled for Nov 02, 2026.
Based on 3 analysts, Sonoma Pharmaceuticals, Inc. Common Stock is expected to report EPS of -$0.10 and revenue of $5.39M for Q2 2027.
Check FXEmpire's Earnings Calendar for today's list of reporting companies.
Advertisement